California Stem Cell Submits FDA Phase III Clinical Trial Protocol...

The multicenter trial will examine the effectiveness of CSC's patient specific cancer immunotherapy in patients with recurrent stage III or stage IV metastatic melanoma.

http://eon.businesswire.com/news/eon/20130726005152/en/California-Stem-Cell-Submits-FDA-Phase-III